LGC Clinical Diagnostics launches a comprehensive DYPD reference material to advance personalized cancer treatment and pharmacogenomics

News - LGC Clinical Diagnostics, a leader in quality solutions for molecular diagnostics, is delighted to announce the launch of the Seraseq® DPYD DNA Mutation Mix. This launch marks LGC Clinical Diagnostics’ entry into the rapidly expanding field of pharmacogenomics, furthering its commitment to personalized medicine. This cutting-edge reference material is designed for developing, validating, and routinely evaluating Next Generation Sequencing (NGS) assays and other molecular assays that detect critical mutations in the DPYD gene.

27 September 2024
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture

News - Melbourne, 19 September 2024 -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications.

19 September 2024
LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

News - LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

26 August 2024
LGC appoints Marcus Kaeller as Chief Financial Officer

News - LGC appoints Marcus Kaeller as Chief Financial Officer

03 June 2024
Pioneering Cancer Treatments through Enhanced Genomic Profiling

News - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

22 February 2024
NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

News - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

25 January 2024
LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning

News - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes 

15 January 2024